Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ZOTEFOAMS PLC Director's Dealing 2025

May 1, 2025

5285_dirs_2025-05-01_0b1f15dc-9b00-47f0-868c-3a052694aeb8.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9285G

Zotefoams PLC

01 May 2025

Zotefoams plc

(the 'Company')

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

1 May 2025 - On 29 April 2025 the Company received notice from its Employee Benefit Trust of the exercise of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's Deferred Bonus Share Plan ('DBSP') as follows:

Director/PDMR Award Number of shares exercised Number of shares retained Share price

£
G C McGrath DBSP 2021 2,125 2,125 2.53

The award was increased to reflect the dividends paid during the restricted period.

The Notification of Dealing Form can be found below.

This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

Enquiries:

Zotefoams plc +44 (0) 208 664 1600
Ronan Cox, Group CEO
Gary McGrath, Group CFO
IFC Advisory +44 (0) 203 934 6630
Graham Herring

Tim Metcalfe

Zach Cohen

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide across three market verticals, Consumer & Lifestyle, Transport & Smart Technologies, and Construction & Other Industrial. Zotefoams uses its own materials to manufacture T-FIT® advanced insulation for demanding industrial markets.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary Christopher McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention of shares under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume Price
2,125 £2.53

d)

Aggregated information:

n/a

e)

Date of the transaction: 29 April 2025

f)

Place of the transaction: XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHIMMRTMTIJBAA